Uncategorized

Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing

FOSTER CITY, Calif. and DURHAM, NC, Sept 12, 2018 – Gilead Sciences (Nasdaq: GILD) and Precision BioSciences announced today that the companies have entered into a strategic collaboration to...


Precision BioSciences Announces Collaboration With University of Pennsylvania to Develop Genome Editing Therapeutics

DURHAM, North Carolina, USA, September 04, 2018 – Precision BioSciences today announced an expansion of their ongoing collaboration with the Gene Therapy Program in the Perelman School of Medicine...


CSO Derek Jantz Discusses Precision's Long History in Genome Editing and the Future of Medicine with PMWC

Precision BioSciences CSO and Co-founder Derek Jantz will present during the Emerging Therapeutics Showcase of the Duke Precision Medicine World Conference (PMWC) on September 25th, 2018 in Durham,...


Penn Announces Publication of Clinically Relevant Genome Editing in Primates Using Precision's ARCUS Platform

Durham, NC July 09, 2018 – The University of Pennsylvania’s Perelman School of Medicine announced today that researchers from Jim Wilson’s Gene Therapy Program have found that using...


Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs

DURHAM, North Carolina, USA, June 26 2018 –Precision BioSciences today announced the closing of an oversubscribed $110M Series B financing to further product development efforts based on its...


Precision BioSciences CSO to Join Gene Therapy Session at DIA 2018

DURHAM, North Carolina, USA, June 20 2018 – Precision BioSciences CSO Derek Jantz will present and join a panel discussion during the DIA (Drug Information Association) 2018 conference session...


Precision PlantSciences Renamed Elo Life Systems

DURHAM, North Carolina, USA, June 04 2018 – Precision BioSciences has announced a new name and brand identity for its food and agriculture business. The new entity, Elo Life Systems, will be held...


Precision BioSciences to Present In Vivo Gene Therapy and Ex Vivo Cancer Immunotherapy Data at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

DURHAM, North Carolina, USA, May 14 2018 – Precision BioSciences, the ARCUS genome editing company with novel product development programs in gene therapy, cancer immunotherapy and non-GMO food,...


Cargill Announces Ongoing Partnership With Precision BioSciences Enabling Healthy Canola Oil Products

Durham, NC Feb. 22, 2018 – Cargill today announced an ongoing partnership with Precision BioSciences to advance its program in healthy canola oils with the lowest saturate levels on the market...


Precision CEO Matt Kane Discusses the Unique Features of ARCUS With PMWC

  On January 22nd 2018, Precision BioSciences CEO and Co-founder Matt Kane will participate in the Silicon Valley Precision Medicine World Conference (PMWC), sharing his insights as part of...


Precision PlantSciences Helps Establish Vision and Goals for Crops of the Future Collaborative

DURHAM, North Carolina, USA, September 19 2017 – President of Precision PlantSciences, Fayaz Khazi, Ph.D., joined the other founding partners of the Crops of the Future (COTF) collaborative in...


David Thomson Joins Precision BioSciences as Chief Development Officer

DURHAM, North Carolina, USA, July 10 2017 – Precision BioSciences is pleased to welcome David Thomson, Ph.D., into a newly created position of Chief Development Officer. At Precision, David will...


Precision PlantSciences partners with Bayer, BioGemma, KWS, FAPESP, Rijk Zwaan and CIMMYT through the FFAR Crops of the Future Collaborative

DURHAM, North Carolina, USA, June 29, 2017 – Precision PlantSciences has signed on to a new initiative supported by the 2014 Farm Bill and run through the non-profit organization the Foundation...


Precision BioSciences Welcomes Fayaz Khazi, Ph.D. as President of PlantSciences

DURHAM, North Carolina, USA, June 16, 2017 – Precision BioSciences has appointed Fayaz Khazi, Ph.D., to serve as the President of Precision PlantSciences, a business unit developing innovative,...


Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology

BANNOCKBURN, Ill. and DURHAM, North Carolina, February 25, 2016 – Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients...